Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study
Le Moigne, E.; Tromeur, C.; Delluc, A.; Gouillou, M.; Alavi, Z.; Lacut, K.; Mottier, D.; Le Gal, G.
Haematologica 101(1): E12-E14
2016
ISSN/ISBN: 1592-8721 PMID: 26452982 DOI: 10.3324/haematol.2015.134882Document Number: 640276
Document emailed within 0-6 h
Related Documents
Le Gal, G.ég.; Kovacs, M.J.; Carrier, M.; Do, K.; Kahn, S.R.; Wells, P.S.; Anderson, D.A.; Chagnon, I.; Solymoss, S.; Crowther, M.; Righini, M.; Lacut, K.; White, R.H.; Vickars, L.; Rodger, M. 2010: Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study Thrombosis and Haemostasis 104(3): 498-503Høibraaten, E.; Qvigstad, E.; Arnesen, H.; Larsen, S.; Wickstrøm, E.; Sandset, P.M. 2000: Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 84(6): 961-967
Betancourt, M.T.; Rodger, M.A. 2007: Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients Acta Chirurgica Belgica 107(6): 636-640
Noguchi, L.M.; Richardson, B.A.; Baeten, J.M.; Hillier, S.L.; Balkus, J.E.; Chirenje, Z.M.; Bunge, K.; Ramjee, G.; Nair, G.; Palanee-Phillips, T.; Selepe, P.; van der Straten, A.; Parikh, U.M.; Gomez, K.; Piper, J.M.; Watts, D.H.; Marrazzo, J.M. 2015: Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study LANCET. HIV 2(7): E279-E287
Lidegaard, Øj.; Nielsen, L.H.; Skovlund, C.W.; Skjeldestad, F.E.; Løkkegaard, E. 2011: Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9 Bmj 343: D6423
Emmerich, J.; Rosendaal, F.R.; Cattaneo, M.; Margaglione, M.; De Stefano, V.; Cumming, T.; Arruda, V.; Hillarp, A.; Reny, J.L. 2001: Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism Thrombosis and Haemostasis 86(3): 809-816
Bird, S.T.; Hartzema, A.G.; Brophy, J.M.; Etminan, M.; Delaney, J.A.C. 2013: Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis Cmaj: Canadian Medical Association Journal 185(2): E115-E120
Akaraborworn, O.; Chittawatanarat, K.; Chatmongkolchart, S.; Kitsiripant, C. 2016: Modalities in Venous Thromboembolism Prophylaxis and Symptomatic Venous Thromboembolism Occurrence in Critically Ill Surgical Patients (THAI-SICU Study) Journal of the Medical Association of Thailand 99(Suppl 6): S112-S117
Gerstman, B.B.; Piper, J.M.; Freiman, J.P.; Tomita, D.K.; Kennedy, D.L.; Ferguson, W.J.; Bennett, R.C. 1990: Oral contraceptive oestrogen and progestin potencies and the incidence of deep venous thromboembolism International Journal of Epidemiology 19(4): 931-936
Spencer, F.A.; Gore, J.M.; Reed, G.; Lessard, D.; Pacifico, L.; Emery, C.; Crowther, M.A.; Goldberg, R.J. 2009: Venous thromboembolism and bleeding in a community setting. the Worcester Venous Thromboembolism Study Thrombosis and Haemostasis 101(5): 878-885
Langman, L.J.; Ray, J.G.; Evrovski, J.; Yeo, E.; Cole, D.E. 2000: Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study Archives of Internal Medicine 160(7): 961-964
Kyrle, P.A.; Eichinger, S.; Pabinger, I.; Stümpflen, A.; Hirschl, M.; Bialonczyk, C.; Schneider, B.; Mannhalter, C.; Melichart, M.; Traxler, G.; Weltermann, A.; Speiser, W.; Lechner, K. 1997: Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism Thrombosis and Haemostasis 77(5): 829-833
Lalude, O.O. 2013: Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study Current Cardiology Reports 15(7): 374
Walker, A.; Campbell, S.; Grimshaw, J. 1999: Implementation of a national guideline on prophylaxis of venous thromboembolism: a survey of acute services in Scotland. Thromboembolism Prevention Evaluation Study Group Health Bulletin 57(2): 141-147
Bergendal, A.; Persson, I.; Odeberg, J.; Sundström, A.; Holmström, M.; Schulman, S.; Björgell, O.; Kieler, H. 2014: Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes Obstetrics and Gynecology 124(3): 600-609
Limdi, J.K.; Farraye, J.; Cannon, R.; Woodhams, E.; Farraye, F.A. 2019: Contraception, Venous Thromboembolism, and Inflammatory Bowel Disease: what Clinicians (and Patients) Should know Inflammatory Bowel Diseases 25(10): 1603-1612
Simioni, P.; Tormene, D.; Prandoni, P.; Girolami, A. 2001: Pregnancy-related recurrent events in thrombophilic women with previous venous thromboembolism Thrombosis and Haemostasis 86(3): 929
Ninet, J. 2003: The risk of maternal venous thromboembolism disease. Synopsis and definition of high-risk groups Annales de Medecine Interne 154(5-6): 301-309
Mäkelburg, A.B.U.; Lijfering, W.M.; Middeldorp, S.; Hamulyák, K.; Veeger, N.J.G.M.; Prins, M.H.; Büller, H.R.; van der Meer, J. 2009: Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia - a prospective family cohort study in asymptomatic subjects Thrombosis and Haemostasis 101(1): 209-212
James, A.H. 2017: Pregnancy, contraception and venous thromboembolism (deep vein thrombosis and pulmonary embolism) Vascular Medicine 22(2): 166-169